BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 16875385)

  • 1. [Acute blood sugar peaks endanger blood vessels: the postprandial situation to be controlled better].
    MMW Fortschr Med; 2006 Jun; 148(26):57. PubMed ID: 16875385
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes. Paradoxical effects of tightly controlled blood sugar.
    Taubes G
    Science; 2008 Oct; 322(5900):365-7. PubMed ID: 18927369
    [No Abstract]   [Full Text] [Related]  

  • 3. [Start of insulin therapy. How to ensure patient compliance?].
    MMW Fortschr Med; 2006 Aug; 148(35-36):12-3. PubMed ID: 16995354
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intensive glucose control in type 2 diabetes is beneficial].
    Nilsson PM; Attvall S
    Lakartidningen; 2009 Sep 2-8; 106(36):2198. PubMed ID: 19817174
    [No Abstract]   [Full Text] [Related]  

  • 5. [Postprandial glycemia in diabetes patients: assessing this indicator].
    Letonturier P
    Presse Med; 2006 Dec; 35(12 Pt 1):1855-6. PubMed ID: 17205659
    [No Abstract]   [Full Text] [Related]  

  • 6. Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus.
    Giugliano D; Ceriello A; Razzoli E; Esposito K
    Clin Drug Investig; 2008; 28(4):199-210. PubMed ID: 18345710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Certain beginning of insulin therapy: yes, we can, but...].
    Rohrer A
    Praxis (Bern 1994); 2009 Mar; 98(6):301. PubMed ID: 19338117
    [No Abstract]   [Full Text] [Related]  

  • 8. Prandial insulin substitution with insulin lispro or insulin lispro mid mixture vs. basal therapy with insulin glargine: a randomized controlled trial in patients with type 2 diabetes beginning insulin therapy.
    Kazda C; Hülstrunk H; Helsberg K; Langer F; Forst T; Hanefeld M
    J Diabetes Complications; 2006; 20(3):145-52. PubMed ID: 16632233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.
    Bastyr EJ; Stuart CA; Brodows RG; Schwartz S; Graf CJ; Zagar A; Robertson KE
    Diabetes Care; 2000 Sep; 23(9):1236-41. PubMed ID: 10977012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.
    Anderson JH; Brunelle RL; Keohane P; Koivisto VA; Trautmann ME; Vignati L; DiMarchi R
    Arch Intern Med; 1997 Jun; 157(11):1249-55. PubMed ID: 9183237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should postprandial hyperglycaemia in prediabetic and type 2 diabetic patients be treated?
    Charpentier G; Riveline JP; Dardari D; Varroud-Vial M
    Drugs; 2006; 66(3):273-86. PubMed ID: 16526817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why are we doing cardiovascular outcome trials in type 2 diabetes?
    Menon V; Aggarwal B
    Cleve Clin J Med; 2014 Nov; 81(11):665-71. PubMed ID: 25368216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].
    MMW Fortschr Med; 2012 Feb; 154(3):82-3. PubMed ID: 22458177
    [No Abstract]   [Full Text] [Related]  

  • 14. Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.
    Feinglos MN; Thacker CH; English J; Bethel MA; Lane JD
    Diabetes Care; 1997 Oct; 20(10):1539-42. PubMed ID: 9314631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.
    Roach ; Koledova E; Metcalfe S; Hultman C; Milicevic Z;
    Clin Ther; 2001 Oct; 23(10):1732-44. PubMed ID: 11726007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes.
    Pfützner A; Küstner E; Forst T; Schulze-Schleppinghoff B; Trautmann ME; Haslbeck M; Schatz H; Beyer J
    Exp Clin Endocrinol Diabetes; 1996; 104(1):25-30. PubMed ID: 8750567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycaemic control in diabetes.
    Herman W
    Clin Evid; 2002 Jun; (7):529-37. PubMed ID: 12230678
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of fasting capillary glucose variability between insulin glargine and NPH.
    Mu P; Lu H; Zhang G; Chen Y; Fu J; Wang M; Shu J; Zeng L
    Diabetes Res Clin Pract; 2011 Jan; 91(1):e4-7. PubMed ID: 20970870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical research. Deaths in diabetes trial challenge a long-held theory.
    Couzin J
    Science; 2008 Feb; 319(5865):884-5. PubMed ID: 18276854
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of daily glucose excursion by continuous glucose monitoring between type 2 diabetic patients receiving preprandial insulin aspart or postprandial insulin glulisine.
    Ohta A; Arai K; Nishine A; Sada Y; Kato H; Fukuda H; Asai S; Nagai Y; Katabami T; Tanaka Y
    Endocr J; 2013; 60(2):173-7. PubMed ID: 23047542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.